Charles River Laboratories International Inc
CRL150.830USD
-1.410-0.93%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
7.42BCap. mercado
PérdidaP/E TTM
Más Datos de Charles River Laboratories International Inc Compañía
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Información de la empresa
Símbolo de cotizaciónCRL
Nombre de la empresaCharles River Laboratories International Inc
Fecha de salida a bolsaJun 23, 2000
Director ejecutivoMr James C. Foster
Número de empleados18600
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 23
Dirección251 Ballardvale St
CiudadWILMINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01887
Teléfono17812226000
Sitio Webhttps://www.criver.com/
Símbolo de cotizaciónCRL
Fecha de salida a bolsaJun 23, 2000
Director ejecutivoMr James C. Foster
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr James C. Foster
Mr James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
12.88K
+69.56%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.48K
-8.77%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Independent Director
Independent Director
3.96K
+31.35%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
2.59K
+155.42%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
2.41K
+64.49%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
946.00
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr James C. Foster
Mr James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment
Management
Corporate Executive Vice President - Discovery and Safety Assessment
Management
12.88K
+69.56%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.48K
-8.77%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Por negocioUSD
Nombre
Ganancia
Proporción
DSA
592.61M
60.21%
RMS
213.07M
21.65%
Manufacturing
178.49M
18.14%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
536.96M
54.56%
Europe
263.25M
26.75%
Canada
125.35M
12.74%
Asia Pacific (Region)
41.94M
4.26%
Other
16.67M
1.69%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
DSA
592.61M
60.21%
RMS
213.07M
21.65%
Manufacturing
178.49M
18.14%
Estadísticas de accionistas
Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.79%
Wellington Management Company, LLP
7.66%
BlackRock Institutional Trust Company, N.A.
5.59%
Allspring Global Investments, LLC
4.66%
State Street Global Advisors (US)
3.78%
Otro
66.54%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.79%
Wellington Management Company, LLP
7.66%
BlackRock Institutional Trust Company, N.A.
5.59%
Allspring Global Investments, LLC
4.66%
State Street Global Advisors (US)
3.78%
Otro
66.54%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
44.29%
Investment Advisor/Hedge Fund
41.00%
Hedge Fund
9.40%
Research Firm
5.94%
Bank and Trust
2.19%
Pension Fund
1.49%
Individual Investor
1.05%
Sovereign Wealth Fund
1.04%
Private Equity
0.20%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
1399
56.14M
114.06%
-4.38M
2025Q1
1435
55.38M
112.72%
-5.93M
2024Q4
1423
54.85M
107.26%
-4.35M
2024Q3
1392
53.78M
105.14%
-5.12M
2024Q2
1399
54.00M
104.84%
-4.00M
2024Q1
1393
53.76M
104.37%
-4.04M
2023Q4
1424
53.56M
104.42%
-4.24M
2023Q3
1446
53.56M
104.42%
-3.98M
2023Q2
1427
52.88M
103.32%
-3.95M
2023Q1
1431
52.72M
103.01%
-2.79M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
6.09M
12.41%
-39.84K
-0.65%
Mar 31, 2025
Wellington Management Company, LLP
4.29M
8.72%
+208.59K
+5.12%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.91M
5.92%
-42.75K
-1.45%
Mar 31, 2025
Allspring Global Investments, LLC
1.77M
3.61%
-33.40K
-1.85%
Mar 31, 2025
State Street Global Advisors (US)
1.90M
3.87%
-278.81K
-12.78%
Mar 31, 2025
Nomura Securities Co., Ltd.
601.62K
1.22%
+293.81K
+95.46%
Mar 31, 2025
Ariel Investments, LLC
1.10M
2.24%
+33.45K
+3.13%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.26M
2.57%
+30.45K
+2.47%
Mar 31, 2025
Invesco Capital Management LLC
981.66K
2%
+78.23K
+8.66%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
